DGM
Darwin Global Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,687,135
| Closed | -$26.7M | – | 6 |
|
|
2024
Q4 | $26.7M | Buy |
1,687,135
+163,403
| +11% | +$2.59M | 2.53% | 5 |
|
|
2024
Q3 | $88.5M | Sell |
1,523,732
-2,170
| -0.1% | -$126K | 7.2% | 4 |
|
|
2024
Q2 | $68.8M | Buy |
1,525,902
+89,952
| +6% | +$4.05M | 8% | 5 |
|
|
2024
Q1 | $95.1M | Buy |
1,435,950
+375,523
| +35% | +$24.9M | 12.66% | 3 |
|
|
2023
Q4 | $42.2M | Buy |
+1,060,427
| New | +$42.2M | 8.28% | 5 |
|
|
2023
Q2 | – | Sell |
-31,386
| Closed | -$1.34M | – | 4 |
|
|
2023
Q1 | $1.34M | Sell |
31,386
-397,146
| -93% | -$17M | 0.37% | 4 |
|
|
2022
Q4 | $20.6M | Buy |
+428,532
| New | +$20.6M | 12.81% | 2 |
|
|
2022
Q1 | – | Sell |
-111,500
| Closed | -$6.52M | – | 7 |
|
|
2021
Q4 | $6.52M | Buy |
+111,500
| New | +$6.52M | 1% | 8 |
|
|
2021
Q3 | – | Sell |
-104,186
| Closed | -$4.43M | – | 16 |
|
|
2021
Q2 | $4.43M | Buy |
104,186
+17,299
| +20% | +$735K | 0.71% | 9 |
|
|
2021
Q1 | $5.35M | Buy |
+86,887
| New | +$5.35M | 1.05% | 8 |
|